Search by Drug Name or NDC
NDC 55154-6777-08 XIFAXAN 550 mg/1 Details
XIFAXAN 550 mg/1
XIFAXAN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cardinal Health 107, LLC. The primary component is RIFAXIMIN.
MedlinePlus Drug Summary
Rifaximin 200-mg tablets are used to treat traveler's diarrhea caused by certain bacteria in adults and children at least 12 years of age. Rifaximin 550-mg tablets are used to prevent episodes of hepatic encephalopathy (changes in thinking, behavior, and personality caused by a build-up of toxins in the brain in people who have liver disease) in adults who have liver disease and to treat irritable bowel syndrome (with diarrhea) in adults. Rifaximin is in a class of medications called antibiotics. Rifaximin treats traveler's diarrhea and irritable bowel syndrome by stopping the growth of the bacteria that cause diarrhea. Rifaximin treats hepatic encephalopathy by stopping the growth of bacteria that produce toxins and that may worsen liver disease. Rifaximin will not work to treat traveler's diarrhea that is bloody or occurs with fever. Antibiotics such as rifaximin will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 55154-6777-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rifaximin
Product Information
NDC | 55154-6777 |
---|---|
Product ID | 55154-6777_39db2c9d-1bcb-4e99-96a7-ae9c6edf9480 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | XIFAXAN |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | rifaximin |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 550 |
Active Ingredient Units | mg/1 |
Substance Name | RIFAXIMIN |
Labeler Name | Cardinal Health 107, LLC |
Pharmaceutical Class | Rifamycin Antibacterial [EPC], Rifamycins [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021361 |
Listing Certified Through | 2024-12-31 |
Package
NDC 55154-6777-08 (55154677708)
NDC Package Code | 55154-6777-8 |
---|---|
Billing NDC | 55154677708 |
Package | 360 TABLET in 1 BOTTLE, PLASTIC (55154-6777-8) |
Marketing Start Date | 2010-05-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |